Itron lists 410 shares for sale valued at $40.9K
The notice lists earlier sales of 58 shares on August 20, 2026, and 76 shares on August 24, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Itron, Inc. (ITRI) lists 410 common shares for sale at an aggregate market value of $40,948.75, with an approximate sale date of November 2, 2026. The securities information names David Marshall Wright as the person for whose account the shares are to be sold; remarks state that the sale occurred in Aaron D. Wright’s account and identify him as the son of David M. Wright, an Itron officer. Acquisition details list restricted-stock vesting of 354 shares on February 26, 2024, and 56 shares on February 27, 2024.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.